Prokidney Corp (PROK) Stock Price, Quote & News

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 336 999 7028

Website: prokidney.com

Address:

2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States

vldz Jul. 15 at 10:29 PM

$PROK Any buyout?

0 · Reply

Bazzzigar Jul. 15 at 8:51 PM

$PROK offering soon

0 · Reply

kxvish Jul. 15 at 8:38 PM

$CYCC $IXHL $PROK

0 · Reply

JK_Capital Jul. 15 at 8:34 PM

$IXHL ready for continuation tmr as we gear up for some spicy data here… Expecting a PR soon, perhaps by the end of the week🫨 Could pull a $PROK or $CYCC type move towards $1 with good data, which the CEO has been hinting at🫣

0 · Reply

WorkHard7 Jul. 15 at 8:24 PM

$PROK this stock is fantastic for day trading. Any opinions on where this bounces up to in the after hours tonight? I would not be surprised if we saw $3.50 a share.

1 · Reply

EZ_Money11 Jul. 15 at 8:03 PM

$PROK Under $3 coming, told you massive gap below! 🔻

0 · Reply

Markag68 Jul. 15 at 7:59 PM

$PROK on a serious note, this is good for a swing trade and sell after hours. It loves to climb before dumping in the morning.

0 · Reply

000ACEZ Jul. 15 at 7:41 PM

$PROK if they have a PIPE investor lined up for the offering, and close it quickly, shorts are toast.

1 · Reply

newmoneyking Jul. 15 at 7:10 PM

$PROK couldn’t even break the lows of yesterday but somehow bears are out and about whining. Keep shorting you’ll learn the hard way.

0 · Reply

Markag68 Jul. 15 at 7:08 PM

$PROK it was $6.80 a week ago, and we told you to sell. It will be under $2 within a week. Even when warned, people think they are smarter.

1 · Reply

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 9, 2025, 11:22 AM EDT - 6 days ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 8:45 AM EDT - 6 days ago

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 7:30 AM EDT - 6 days ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 8, 2025, 5:09 PM EDT - 7 days ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 1:25 PM EDT - 7 days ago

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 9:05 AM EDT - 7 days ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 7:00 AM EDT - 7 days ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 1, 2025, 12:43 PM EDT - 14 days ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

May 12, 2025, 4:15 PM EDT - 2 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 4 months ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Jan 31, 2025, 11:08 AM EST - 5 months ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 6:10 AM EST - 5 months ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Nov 26, 2024, 7:30 AM EST - 8 months ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 12, 2024, 7:30 AM EST - 8 months ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 5, 2024, 7:30 AM EST - 9 months ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Oct 14, 2024, 7:30 AM EDT - 9 months ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 9, 2024, 7:30 AM EDT - 9 months ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Sep 3, 2024, 7:30 AM EDT - 11 months ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Aug 27, 2024, 7:30 AM EDT - 11 months ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

Mar 25, 2024, 6:05 AM EDT - 1 year ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 21, 2024, 7:49 PM EDT - 1 year ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Feb 29, 2024, 4:05 PM EST - 1 year ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Nov 30, 2023, 6:05 AM EST - 1 year ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 21, 2023, 6:05 AM EST - 1 year ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 16, 2023, 4:40 PM EST - 1 year ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:05 AM EST - 1 year ago

ProKidney Reports Third Quarter Financial Results

Nov 13, 2023, 5:02 PM EST - 1 year ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Oct 30, 2023, 4:12 PM EDT - 1 year ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Jul 18, 2023, 6:05 AM EDT - 2 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 15, 2023, 2:02 AM EDT - 2 years ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jun 13, 2023, 12:05 PM EDT - 2 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

Jun 1, 2023, 4:05 PM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

May 11, 2023, 4:01 PM EDT - 2 years ago

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 4, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Present at the BofA Securities Health Care Conference 2023

Apr 12, 2023, 11:51 AM EDT - 2 years ago

ProKidney: Too Many Billionaires, Too Little Data

Mar 28, 2023, 4:12 PM EDT - 2 years ago

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

Mar 3, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in TD Cowen's 43rd Annual Health Care Conference

Jan 11, 2023, 7:48 AM EST - 2 years ago

ProKidney's stock jumps 29%

Jan 10, 2023, 4:05 PM EST - 2 years ago

ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease

Dec 22, 2022, 6:05 AM EST - 2 years ago

ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference

vldz Jul. 15 at 10:29 PM

$PROK Any buyout?

0 · Reply

Bazzzigar Jul. 15 at 8:51 PM

$PROK offering soon

0 · Reply

kxvish Jul. 15 at 8:38 PM

$CYCC $IXHL $PROK

0 · Reply

JK_Capital Jul. 15 at 8:34 PM

0 · Reply

WorkHard7 Jul. 15 at 8:24 PM

$PROK this stock is fantastic for day trading. Any opinions on where this bounces up to in the after hours tonight? I would not be surprised if we saw $3.50 a share.

1 · Reply

EZ_Money11 Jul. 15 at 8:03 PM

$PROK Under $3 coming, told you massive gap below! 🔻

0 · Reply

Markag68 Jul. 15 at 7:59 PM

$PROK on a serious note, this is good for a swing trade and sell after hours. It loves to climb before dumping in the morning.

0 · Reply

000ACEZ Jul. 15 at 7:41 PM

$PROK if they have a PIPE investor lined up for the offering, and close it quickly, shorts are toast.

1 · Reply

newmoneyking Jul. 15 at 7:10 PM

$PROK couldn’t even break the lows of yesterday but somehow bears are out and about whining. Keep shorting you’ll learn the hard way.

0 · Reply

Markag68 Jul. 15 at 7:08 PM

$PROK it was $6.80 a week ago, and we told you to sell. It will be under $2 within a week. Even when warned, people think they are smarter.

1 · Reply

Rampageusa Jul. 15 at 7:05 PM

$PROK hit double bottom at 3.3 so buish, $HOLO double top at 6.3 so bearish… market is wild..

0 · Reply

StockCarnage Jul. 15 at 7:03 PM

$IXHL This is only the beginning. Took profits from $SBET and $PROK moved to $IXHL. Wait for the release on results expected July 2025 on sleep apnea. Cancelled dilution warrants. On track for first FDA approved drug with synthesized THC for Sleep Apnea. I wasn't expecting moves until the news but we are now blessed. Target .50-.60 by tomorrow until the 300-600% run after the news. PT $3.00+

0 · Reply

dbr_island Jul. 15 at 6:56 PM

$KAPA LFG!!!!! 💰💰💰💰 $BLMZ $PROK $XAGE $IXHL LFG!!!!!

0 · Reply

Markag68 Jul. 15 at 6:54 PM

$PROK will it hold for the ssr or keep dumping? Charts mean nothing when they are dumping $200M

0 · Reply

Thess5 Jul. 15 at 6:54 PM

$PROK Back over $3.50 by EOD. Patience

0 · Reply

Thess5 Jul. 15 at 6:53 PM

$PROK Bullish wedge

0 · Reply

Rajankduggy Jul. 15 at 6:41 PM

$PROK Don’t day you wasn’t warned …where’s all the loud mouths that were patting me earlier now? Stay humble people , whoever lost on this may you make all that money back and then some, maybe even via a few of my short call outs , amen

0 · Reply

dbr_island Jul. 15 at 6:37 PM

$PLRZ is back above $1 Keep your eye on this ticker folks Could get interesting with its history $ZBAI the consolidation before the ESCALATION $KAPA quietly adding this before the $PROK type run as that news was MASSIVE $IXHL watching

0 · Reply

View2021 Jul. 15 at 6:36 PM

$PROK setting up nicely for a pop back to $6

0 · Reply

Takeiteasy30 Jul. 15 at 6:36 PM

$IXHL Yeah , this guy is something else i saw him at $PROK he was reading tape like a news paper magazine I am giving respect where its due.

0 · Reply

cheating_stock_investor Jul. 15 at 6:09 PM

$PROK good buy on the dip here to trend up. Two banks believe this is worth 8 to 10

0 · Reply

shavitmi Jul. 15 at 6:00 PM

$PROK $SPRC $IXHL

0 · Reply

Market Cap	1.33B
Revenue (ttm)	80,000.00
Net Income (ttm)	-61.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-76,487.50%
Debt to Equity Ratio	0.00

Volume	34,433,793
Avg Vol	14,351,860
Day's Range	N/A - N/A
Shares Out	292.70M
Stochastic %K	48%
Beta	1.26
Analysts	Sell
Price Target	$4.83